Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Cell adhesion inhibitors claimed by Nippon Shinyaku

Jan. 23, 1997

Toyama discloses antiplatelet agents

Jan. 23, 1997

New endothelin antagonists from Zeneca

Jan. 22, 1997

New agents for treating encephalopathies from Takeda

Jan. 22, 1997

New antimigraine drug candidates from Lilly

Jan. 22, 1997

Yamanouchi reports 5-HT3 agonists for GI indications

Jan. 22, 1997

Histamine H3 receptor antagonists in development at Gliatech

Jan. 22, 1997

GI motility stimulants reported by Janssen

Jan. 22, 1997

New 5-HT1A receptor ligands reported by Bayer

Jan. 21, 1997

New cardiovascular agents from Sigma-Tau

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...